1974
DOI: 10.1146/annurev.me.25.020174.002001
|View full text |Cite
|
Sign up to set email alerts
|

Biogenic Amines and Affective Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

1976
1976
2012
2012

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 95 publications
(12 citation statements)
references
References 0 publications
0
12
0
Order By: Relevance
“…A reduced WPV was repeatedly found in psychiatric patients. In patients with depressive psychoses, reduced levels of monoamine metabolites in the CSF were found (6,12,22,24), and in patients with schizophrenia, recent reports have indicated that there is a reduction of mono amine oxidase activity in blood platelets, indicating disturbances in the mono amine turn-over (5). The correlations between monoamine metabolites and EEG measures that we found are in line with these investigations.…”
Section: Discussionmentioning
confidence: 99%
“…A reduced WPV was repeatedly found in psychiatric patients. In patients with depressive psychoses, reduced levels of monoamine metabolites in the CSF were found (6,12,22,24), and in patients with schizophrenia, recent reports have indicated that there is a reduction of mono amine oxidase activity in blood platelets, indicating disturbances in the mono amine turn-over (5). The correlations between monoamine metabolites and EEG measures that we found are in line with these investigations.…”
Section: Discussionmentioning
confidence: 99%
“…Initial studies focused on known neurotransmitter systems such as biogenic amines (Cousins et al, 2009; Manji and Lenox, 2000; Schildkraut, 1974), glutamate, and GABA (Krystal et al, 2002; Post, 1990), and on altered regulation of glucocorticoids (Daban et al, 2005; Watson et al, 2004), with implications of an involvement of each system. Studies with lithium led to the hypothesis of a role of the glycogen synthase kinase 3 beta pathway (Ikonomov and Manji, 1999; Klein and Melton, 1996), while studies with valproic acid introduced a role for epigenetic mechanisms in BPD (Phiel et al, 2001).…”
Section: Major Gene Groups Of Interest In Bipolar Disorder: Rounding mentioning
confidence: 99%
“…In view of known derangements in monoaminergic function in Parkinson's disease (Hornykiewicz, 1971), postulated abnormalities in affective psychoses (Schildkraut, 1974), and changes in urinary excretion of cAMP in manic-depressive illness (Paul et al, 1971;Abdulla and Hamadah, 1970), various authors have looked for alterations in cAMP concentration in lumbar cerebrospinal fluid (LCSF) in various neurological (Cramer et al, 1973) and psychiatric disorders (Robison et al, 1970;Cramer et al, 1972a). Unfortunately, little information is available on the relative contribution of brain and spinal cord to the concentration of cAMP in LCSF so that interpreta-tion of results based on LCSF findings must be made with caution.…”
mentioning
confidence: 99%